FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donata Rimoldi

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Sergey I Nikolaev; Donata Rimoldi; Daniel Robyr; Daniel Speiser; Brian J Stevenson; Armand Valsesia; Ioannis Xenarios; Vincent Zoete; Jacques Beckmann; Olesya Bukach; Corinne Gehrig; Michel Guipponi; Thanos D Halazonetis; Keith Harshman; Christian Iseli; Victor Jongeneel; Olivier Michielin; Katja Muehlethaler; Stylianos E Antonarakis
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
Lukas Baitsch; Leticia Barba; Petra Baumgaertner; Hanifa Bouzourene; Céline Christiansen-Jucht; Silvia A Fuertes Marraco; Amandine Legat; Maurice Matter; Olivier Michielin; Hanspeter Pircher; Donata Rimoldi; Jean-Paul Rivals; Nathalie Rufer; Daniel E Speiser
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.
Bruno Salaun; Laurence Zitvogel; Carine Asselin-Paturel; Yannis Morel; Karine Chemin; Clarisse Dubois; Catherine Massacrier; Rosa Conforti; Marie Pierre Chenard; Jean-Christophe Sabourin; Aicha Goubar; Serge Lebecque; Michel Pierres; Donata Rimoldi; Pedro Romero; Fabrice Andre
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donata Rimoldi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sergey I Nikolaev; Donata Rimoldi; Daniel Robyr; Daniel Speiser; Brian J Stevenson; Armand Valsesia; Ioannis Xenarios; Vincent Zoete; Jacques Beckmann; Olesya Bukach; Corinne Gehrig; Michel Guipponi; Thanos D Halazonetis; Keith Harshman; Christian Iseli; Victor Jongeneel; Olivier Michielin; Katja Muehlethaler; Stylianos E Antonarakis
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.
Nature genetics 2012;44(2):133-9.
2012: Lukas Baitsch; Leticia Barba; Petra Baumgaertner; Hanifa Bouzourene; Céline Christiansen-Jucht; Silvia A Fuertes Marraco; Amandine Legat; Maurice Matter; Olivier Michielin; Hanspeter Pircher; Donata Rimoldi; Jean-Paul Rivals; Nathalie Rufer; Daniel E Speiser
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.
PloS one 2012;7(2):e30852.
2011: Bruno Salaun; Laurence Zitvogel; Carine Asselin-Paturel; Yannis Morel; Karine Chemin; Clarisse Dubois; Catherine Massacrier; Rosa Conforti; Marie Pierre Chenard; Jean-Christophe Sabourin; Aicha Goubar; Serge Lebecque; Michel Pierres; Donata Rimoldi; Pedro Romero; Fabrice Andre
TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer.
Cancer research 2011;71(5):1607-14.
2011: Armand Valsesia; Donata Rimoldi; Danielle Martinet; Mark Ibberson; Paola Benaglio; Manfredo Quadroni; Patrice Waridel; Muriel Gaillard; Mireille Pidoux; Blandine Rapin; C Rivolta; Ioannis Xenarios; Andrew J G Simpson; Stylianos E Antonarakis; Jacques Beckmann; Victor Jongeneel; Christian Iseli; Brian J Stevenson
Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.
PloS one 2011;6(4):e18369.
2010: julien laurent; Daniel E Speiser; Victor Appay; Cedric Touvrey; Manuela Vicari; Anne Papaioannou; Giorgia Canellini; Donata Rimoldi; Nathalie Rufer; Pedro Romero; Serge Leyvraz; Verena Voelter
Impact of 3 different short-term chemotherapy regimens on lymphocyte-depletion and reconstitution in melanoma patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(7):723-34.
2010: Claudia Baumann; Cecilia K Lindholm; Donata Rimoldi; Frédéric Lévy
The E3 ubiquitin ligase Itch regulates sorting nexin 9 through an unconventional substrate recognition domain.
The FEBS journal 2010;277(13):2803-14.
2010: Laurent Derré; Jean-Paul Rivals; Camilla Jandus; Sonia Pastor; Donata Rimoldi; Pedro Romero; Olivier Michielin; Daniel Olive; Daniel E Speiser
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
The Journal of clinical investigation 2010;120(1):157-67.
2009: Danielle Lienard; Marie-Françoise Avril; Frédérique-Anne Le Gal; Petra Baumgaertner; Wim Vermeulen; Astrid Blom; Christine Geldhof; Donata Rimoldi; sonia pagliusi; Pedro Romero; Pierre-Yves Dietrich; Nathalie Corvaia; Daniel E Speiser
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(8):875-83.
2008: Verena Voelter; Annie-Claire Diserens; Alexandre Moulin; Georg Nagel; Pu Yan; Eugenia Migliavacca; Donata Rimoldi; Marie-France Hamou; Bernd Kaina; Serge Leyvraz; Monika E Hegi
Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.
International journal of cancer. Journal international du cancer 2008;123(5):1215-8.
2008: Nicolò Brembilla; Johann Weber; Donata Rimoldi; Sylvain Pradervand; Frédéric Schütz; Giuseppe Pantaleo; Curzio Rüegg; Manfredo Quadroni; Keith Harshman; Marie-Agnès Doucey
c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells.
Blood 2008;112(3):652-60.
2008: Verena Voelter; Alessia Pica; julien laurent; Donata Rimoldi; Hanifa Bouzourene; Ali Sajadi; Maurice Matter; Pedro Romero; Nathalie Rufer; Daniel E Speiser
An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.
Cancer immunity 2008;8():6.
2007: Bruno Salaun; Serge Lebecque; Sampsa Matikainen; Donata Rimoldi; Pedro Romero
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4565-74.
2007: Bruce Elliott; Richard A Scolyer; Stefan Suciu; Serge Lebecque; Donata Rimoldi; Oliver Gugerli; Elena MUSAT; Raghwa N Sharma; Danielle Lienard; Ulrich Keilholz; Alessandro Testori; Alexander M M Eggermont; Rona MacKie; Caroline Robert; Martin Cook; John F Thompson; Eric Angevin; Alain Spatz
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(13):3825-30.
2007: Ferdy J Lejeune; Donata Rimoldi; Daniel Speiser
New approaches in metastatic melanoma: biological and molecular targeted therapies.
Expert review of anticancer therapy 2007;7(5):701-13.
2006: Gilles Bioley; Camilla Jandus; Sandra Tuyaerts; Donata Rimoldi; William W Kwok; Daniel E Speiser; Jean-Marie Tiercy; Kris Thielemans; Jean-Charles Cerottini; Pedro Romero
Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6769-79.
2006: Victor Appay; Camilla Jandus; Verena Voelter; Severine Reynard; Sarah E Coupland; Donata Rimoldi; Danielle Lienard; Philippe Guillaume; Arthur M Krieg; Jean-Charles Cerottini; Pedro Romero; Serge Leyvraz; Nathalie Rufer; Daniel E Speiser
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(3):1670-8.
2006: Daniel E Speiser; Petra Baumgaertner; Catherine Barbey; Verena Rubio-Godoy; Alexandre Moulin; Patricia Corthesy; Estelle Devevre; Pierre-Yves Dietrich; Donata Rimoldi; Danielle Liénard; Jean-Charles Cerottini; Pedro Romero; Nathalie Rufer
A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(2):1338-48.
2006: Pascal Batard; Daniel A Peterson; Estelle Devêvre; Philippe Guillaume; Jean-Charles Cerottini; Donata Rimoldi; Daniel E Speiser; Lars Winther; Pedro Romero
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.
Journal of immunological methods 2006;310(1-2):136-48.
2006: Petra Baumgaertner; Nathalie Rufer; Estelle Devevre; Laurent Derré; Donata Rimoldi; Christine Geldhof; Verena Voelter; Danielle Liénard; Pedro Romero; Daniel E Speiser
Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.
Cancer research 2006;66(4):1912-6.
2005: Maha Ayyoub; Andrea Merlo; Charles Hesdorffer; Donata Rimoldi; Daniel Speiser; Jean-Charles Cerottini; Yao-Tseng Chen; Lloyd J Old; Stefan Stevanovic; Danila Valmori
CD4+ T cell responses to SSX-4 in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(8):5092-9.
2005: Frédéric Lévy; Katja Muehlethaler; Suzanne Salvi; Anne-Lise Peitrequin; Cecilia K Lindholm; Jean-Charles Cerottini; Donata Rimoldi
Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation.
Molecular biology of the cell 2005;16(4):1777-87.
2005: Daniel E Speiser; Danielle Liénard; Nathalie Rufer; Verena Rubio-Godoy; Donata Rimoldi; Ferdy Lejeune; Arthur M Krieg; Jean-Charles Cerottini; Pedro Romero
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
The Journal of clinical investigation 2005;115(3):739-46.
2005: Gabriel Bricard; Hanifa Bouzourene; Olivier Martinet; Donata Rimoldi; Nermin Halkic; Michel Gillet; Pascal Chaubert; H Robson MacDonald; Pedro Romero; Jean-Charles Cerottini; Daniel E Speiser
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(3):1709-16.
2005: Maha Ayyoub; Andrea Merlo; Charles Hesdorffer; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Yao-Tseng Chen; Lloyd J Old; Stefan Stevanovic; Danila Valmori
Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.
Clinical immunology (Orlando, Fla.) 2005;114(1):70-8.
2004: Ronit Lahav; Mario-Luca Suvà; Donata Rimoldi; Paul H Patterson; Ivan Stamenkovic
Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.
Cancer research 2004;64(24):8945-53.
2004: Danielle Liénard; Donata Rimoldi; Marie Marchand; Pierre-Yves Dietrich; Nicolas van Baren; Christine Geldhof; Pascal Batard; Philippe Guillaume; Maha Ayyoub; Mikaël J Pittet; Alfred Zippelius; Katharina Fleischhauer; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero; Daniel E Speiser
Ex vivo detectable activation of Melan-A-specific T cells correlating with inflammatory skin reactions in melanoma patients vaccinated with peptides in IFA.
Cancer immunity 2004;4():4.
2004: Alfred Zippelius; Pascal Batard; Verena Rubio-Godoy; Gilles Bioley; Danielle Liénard; Ferdy Lejeune; Donata Rimoldi; Philippe Guillaume; Norbert Meidenbauer; Andreas Mackensen; Nathalie Rufer; Norbert Lubenow; Daniel Speiser; Jean-Charles Cerottini; Pedro Romero; Mikaël J Pittet
Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.
Cancer research 2004;64(8):2865-73.
2004: Maha Ayyoub; Charles Hesdorffer; Monica Montes; Andrea Merlo; Daniel Speiser; Donata Rimoldi; Jean-Charles Cerottini; Gerd Ritter; Matthew Scanlan; Lloyd J Old; Danila Valmori
An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
The Journal of clinical investigation 2004;113(8):1225-33.
2004: Mojgan Movassagh; Alain Spatz; Jean Davoust; Serge Lebecque; Pedro Romero; Mikaël Pittet; Donata Rimoldi; Danielle Liénard; Oliver Gugerli; Laurent Ferradini; Caroline Robert; Marie-Françoise Avril; Laurence Zitvogel; Eric Angevin
Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.
Cancer research 2004;64(6):2192-8.
2003: Daniel E Speiser; Mikaël J Pittet; Donata Rimoldi; Philippe Guillaume; Immanuel F Luescher; Danielle Liénard; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells.
Seminars in cancer biology 2003;13(6):461-72.
2003: Danila Valmori; Valérie Dutoit; Maha Ayyoub; Donata Rimoldi; Philippe Guillaume; Danielle Liénard; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero; Daniel E Speiser
Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
Cancer immunity 2003;3():15.
2003: Donata Rimoldi; Robert Lemoine; Anne-Marie Kurt; Suzanne Salvi; Magali Berset; Maurice Matter; Bruno Roche; Jean-Philippe Cerottini; David Guggisberg; Joachim Krischer; Ralph Braun; Jean-Pierre Willi; Christian Antonescu; Daniel O Slosman; Ferdy J Lejeune; Danielle Liénard
Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
Melanoma research 2003;13(5):511-20.
2003: Donata Rimoldi; Suzanne Salvi; Danielle Liénard; Ferdy J Lejeune; Daniel Speiser; Leonidas Zografos; Jean-Charles Cerottini
Lack of BRAF mutations in uveal melanoma.
Cancer research 2003;63(18):5712-5.
2003: Daniel E Speiser; Donata Rimoldi; Pascal Batard; Danielle Liénard; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
Disease-driven T cell activation predicts immune responses to vaccination against melanoma.
Cancer immunity 2003;3():12.
2003: Maha Ayyoub; Donata Rimoldi; Philippe Guillaume; Pedro Romero; Jean-Charles Cerottini; Danila Valmori; Daniel Speiser
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.
Cancer research 2003;63(17):5601-6.
2003: Maha Ayyoub; Alfred Zippelius; Mikaël J Pittet; Donata Rimoldi; Danila Valmori; Jean-Charles Cerottini; Pedro Romero; Ferdy Lejeune; Danielle Liénard; Daniel E Speiser
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):669-77.
2002: Pedro Romero; Mikael Pittet; Valérie Dutoit; Alfred Zippelius; Danielle Liénard; Ferdy Lejeune; Philippe Guillaume; Donata Rimoldi; Danila Valmori; Daniel E Speiser; Jean-Charles Cerottini
Therapeutic cancer vaccines based on molecularly defined human tumor antigens.
Vaccine 2002;20 Suppl 4():A2-7.
2002: Pedro Romero; Danila Valmori; Mikaël J Pittet; Alfred Zippelius; Donata Rimoldi; Frédéric Lévy; Valérie Dutoit; Maha Ayyoub; Verena Rubio-Godoy; Olivier Michielin; Philippe Guillaume; Pascal Batard; Immanuel F Luescher; Ferdy Lejeune; Danielle Liénard; Nathalie Rufer; Pierre-Yves Dietrich; Daniel E Speiser; Jean-Charles Cerottini
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.
Immunological reviews 2002;188():81-96.
2002: Ann M De Mazière; Katja Muehlethaler; Elly van Donselaar; Suzanne Salvi; Jean Davoust; Jean-Charles Cerottini; Frédéric Lévy; Jan W Slot; Donata Rimoldi
The melanocytic protein Melan-A/MART-1 has a subcellular localization distinct from typical melanosomal proteins.
Traffic (Copenhagen, Denmark) 2002;3(9):678-93.
2002: Verena Rubio-Godoy; Maha Ayyoub; Valérie Dutoit; Catherine Servis; Amy Schink; Donata Rimoldi; Pedro Romero; Jean-Charles Cerottini; Richard Simon; Yindong Zhao; Richard A Houghten; Clemencia Pinilla; Danila Valmori
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity.
European journal of immunology 2002;32(8):2292-9.
2002: Danila Valmori; Valérie Dutoit; Valerie Schnuriger; Anne-Lise Quiquerez; Mikaël J Pittet; Philippe Guillaume; Verena Rubio-Godoy; Paul R Walker; Donata Rimoldi; Danielle Liénard; Jean-Charles Cerottini; Pedro Romero; Pierre-Yves Dietrich
Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(8):4231-40.
2002: Danila Valmori; Carmen Scheibenbogen; Valérie Dutoit; Dirk Nagorsen; Anne Marie Asemissen; Verena Rubio-Godoy; Donata Rimoldi; Philippe Guillaume; Pedro Romero; Dirk Schadendorf; Martin Lipp; Pierre-Yves Dietrich; Eckhard Thiel; Jean-Charles Cerottini; Danielle Liénard; Ulrich Keilholz
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity.
Cancer research 2002;62(6):1743-50.
2002: Daniel E Speiser; Danielle Liénard; Mikaël J Pittet; Pascal Batard; Donata Rimoldi; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.
European journal of immunology 2002;32(3):731-41.
2002: Maha Ayyoub; Stefan Stevanovic; Ugur Sahin; Philippe Guillaume; Catherine Servis; Donata Rimoldi; Danila Valmori; Pedro Romero; Jean-Charles Cerottini; Hans-Georg Rammensee; Michael Pfreundschuh; Daniel Speiser; Frédéric Lévy
Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1717-22.
2002: Valérie Dutoit; Verena Rubio-Godoy; Marie-Agnès Doucey; Pascal Batard; Danielle Liénard; Donata Rimoldi; Daniel Speiser; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero; Danila Valmori
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1167-71.
2001: Donata Rimoldi; Katja Muehlethaler; Suzanne Salvi; Danila Valmori; Pedro Romero; Jean-Charles Cerottini; F Levy
Subcellular localization of the melanoma-associated protein Melan-AMART-1 influences the processing of its HLA-A2-restricted epitope.
The Journal of biological chemistry 2001;276(46):43189-96.
2001: Verena Rubio-Godoy; Valérie Dutoit; Donata Rimoldi; Danielle Lienard; Ferdy Lejeune; Daniel Speiser; Philippe Guillaume; Jean-Charles Cerottini; Pedro Romero; Danila Valmori
Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10302-7.
2001: Valérie Dutoit; Verena Rubio-Godoy; Pierre-Yves Dietrich; A L Quiqueres; Valerie Schnuriger; Donata Rimoldi; Danielle Liénard; Daniel Speiser; Philippe Guillaume; Pascal Batard; Jean-Charles Cerottini; Pedro Romero; Danila Valmori
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity.
Cancer research 2001;61(15):5850-6.
2001: Mikaël J Pittet; Daniel E Speiser; Danielle Liénard; Danila Valmori; Philippe Guillaume; Valérie Dutoit; Donata Rimoldi; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
Expansion and functional maturation of human tumor antigen-specific CD8+ T cells after vaccination with antigenic peptide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):796s-803s.
2001: Pedro Romero; Valérie Dutoit; Verena Rubio-Godoy; Danielle Liénard; Daniel Speiser; Philippe Guillaume; K Servis; Donata Rimoldi; Jean-Charles Cerottini; Danila Valmori
CD8+ T-cell response to NY-ESO-1: relative antigenicity and in vitro immunogenicity of natural and analogue sequences.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):766s-772s.
2001: M Berset; Jean-Philippe Cerottini; David Guggisberg; Pedro Romero; F Burri; Donata Rimoldi; Renato G Panizzon
Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.
International journal of cancer. Journal international du cancer 2001;95(1):73-7.
2001: Danila Valmori; Valérie Dutoit; Verena Rubio-Godoy; C Chambaz; Danielle Liénard; Philippe Guillaume; Pedro Romero; Jean-Charles Cerottini; Donata Rimoldi
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma.
Cancer research 2001;61(2):509-12.
2000: Donata Rimoldi; Verena Rubio-Godoy; Valérie Dutoit; Danielle Lienard; Suzanne Salvi; Philippe Guillaume; Daniel Speiser; E Stockert; G Spagnoli; Catherine Servis; Jean-Charles Cerottini; Ferdy Lejeune; Pedro Romero; Danila Valmori
Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(12):7253-61.
2000: Danila Valmori; Valérie Dutoit; Danielle Liénard; Donata Rimoldi; Mikaël J Pittet; Patrick Champagne; Kim Ellefsen; U Sahin; Daniel Speiser; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients.
Cancer research 2000;60(16):4499-506.
2000: Danila Valmori; Valérie Dutoit; Danielle Liénard; Ferdy Lejeune; Daniel Speiser; Donata Rimoldi; Vincenzo Cerundolo; Pierre-Yves Dietrich; Jean-Charles Cerottini; Pedro Romero
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):533-8.
2000: Danila Valmori; Frédéric Lévy; Isabelle Miconnet; Paul Zajac; Giulio C Spagnoli; Donata Rimoldi; Danielle Liénard; Vincenzo Cerundolo; Jean-Charles Cerottini; Pedro Romero
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):1125-31.
1999: Danila Valmori; Jean-François Fonteneau; Salvatore Valitutti; Nadine Gervois; R Dunbar; Danielle Liénard; Donata Rimoldi; Vincenzo Cerundolo; Francine Jotereau; Jean-Charles Cerottini; Daniel E Speiser; Pedro Romero
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
International immunology 1999;11(12):1971-80.
1999: A Serrano; Bernard Lethé; J M Delroisse; Christophe Lurquin; Etienne De Plaen; Francis Brasseur; Donata Rimoldi; Thierry Boon
Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.
International journal of cancer. Journal international du cancer 1999;83(5):664-9.
1999: Daniel E Speiser; Mikaël J Pittet; Danila Valmori; R Dunbar; Donata Rimoldi; Danielle Liénard; H Robson MacDonald; Jean-Charles Cerottini; Vincenzo Cerundolo; Pedro Romero
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1999;190(6):775-82.
1999: Donata Rimoldi; S Salvi; D Reed; Pierre G Coulie; Victor Jongeneel; Etienne De Plaen; Francis Brasseur; A M Rodriguez; T Boon; Jean-Charles Cerottini
cDNA and protein characterization of human MAGE-10.
International journal of cancer. Journal international du cancer 1999;82(6):901-7.
1999: Danila Valmori; Mikaël J Pittet; C Vonarbourg; Donata Rimoldi; Danielle Liénard; Daniel Speiser; R Dunbar; Vincenzo Cerundolo; Jean-Charles Cerottini; Pedro Romero
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Cancer research 1999;59(16):4050-5.
1999: Daniel E Speiser; Danila Valmori; Donata Rimoldi; Mikaël J Pittet; Danielle Liénard; Vincenzo Cerundolo; H Robson MacDonald; Jean-Charles Cerottini; Pedro Romero
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
European journal of immunology 1999;29(6):1990-9.
1999: Danila Valmori; Mikaël J Pittet; Donata Rimoldi; Danielle Liénard; R Dunbar; Vincenzo Cerundolo; Ferdy Lejeune; Jean-Charles Cerottini; Pedro Romero
An antigen-targeted approach to adoptive transfer therapy of cancer.
Cancer research 1999;59(9):2167-73.
1999: Ying Men; Isabelle Miconnet; Danila Valmori; Donata Rimoldi; Jean-Charles Cerottini; Pedro Romero
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(6):3566-73.
1998: Danila Valmori; Nadine Gervois; Donata Rimoldi; Jean-François Fonteneau; Anilza Bonelo; Danielle Liénard; L Rivoltini; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6956-62.
1998: Pedro Romero; P R Dunbar; Danila Valmori; Mikaël J Pittet; G S Ogg; Donata Rimoldi; J L Chen; Danielle Liénard; Jean-Charles Cerottini; Vincenzo Cerundolo
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
The Journal of experimental medicine 1998;188(9):1641-50.
1998: Michael Hahne; Takao Kataoka; M Schröter; Kay Hofmann; M Irmler; Jean-Luc Bodmer; Pascal Schneider; T Bornand; Nils Holler; Lars E French; Bernard Sordat; Donata Rimoldi; Jürg Tschopp
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.
The Journal of experimental medicine 1998;188(6):1185-90.
1998: Danila Valmori; Jean-François Fonteneau; C M Lizana; Nadine Gervois; Danielle Liénard; Donata Rimoldi; Victor Jongeneel; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1750-8.
1998: Toufic Renno; Antoine Attinger; Donata Rimoldi; Michael Hahne; Jürg Tschopp; H Robson MacDonald
Expression of B220 on activated T cell blasts precedes apoptosis.
European journal of immunology 1998;28(2):540-7.
1998: Jean-Charles Cerottini; Danila Valmori; Donata Rimoldi; Pedro Romero
Human tumor immunotherapy. New opportunities as well as new challenges.
Advances in experimental medicine and biology 1998;451():247-50.
1997: D S Reed; Pedro Romero; Donata Rimoldi; Jean-Charles Cerottini; J Schaack; Victor Jongeneel
Construction and characterization of a recombinant adenovirus directing expression of the MAGE-1 tumor-specific antigen.
International journal of cancer. Journal international du cancer 1997;72(6):1045-55.
1997: R R Hartmann; Donata Rimoldi; Ferdy J Lejeune; S Carrel
Cell differentiation and cell-cycle alterations by tyrosine kinase inhibitors in human melanoma cells.
Melanoma research 1997;7 Suppl 2():S27-33.
1997: M Irmler; Margot Thome; Michael Hahne; Pascal Schneider; Kay Hofmann; V Steiner; Jean-Luc Bodmer; M Schröter; Kimberly Burns; C Mattmann; Donata Rimoldi; Lars E French; Jürg Tschopp
Inhibition of death receptor signals by cellular FLIP.
Nature 1997;388(6638):190-5.
1997: G A Waanders; Donata Rimoldi; Danielle Liénard; S Carrel; Ferdy Lejeune; P Y Dietrich; Jean-Charles Cerottini; Pedro Romero
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):685-96.
1997: Danila Valmori; Danielle Liénard; G Waanders; Donata Rimoldi; Jean-Charles Cerottini; Pedro Romero
Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
Cancer research 1997;57(4):735-41.
1996: Michael Hahne; Donata Rimoldi; M Schröter; Pedro Romero; M Schreier; Lars E French; Pascal Schneider; T Bornand; A Fontana; D Lienard; Jean-Charles Cerottini; Jürg Tschopp
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.
Science (New York, N.Y.) 1996;274(5291):1363-6.
1996: S Carrel; M Schreyer; G Spagnoli; Jean-Charles Cerottini; Donata Rimoldi
Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells.
International journal of cancer. Journal international du cancer 1996;67(3):417-22.
1996: K A Mulcahy; Donata Rimoldi; Francis Brasseur; S Rodgers; D Liénard; M Marchand; I G Rennie; Anna K Murray; C A McIntyre; K E Platts; S Leyvraz; Thierry Boon; Robert C Rees
Infrequent expression of the MAGE gene family in uveal melanomas.
International journal of cancer. Journal international du cancer 1996;66(6):738-42.
1996: Immanuel F Luescher; Pedro Romero; D Kuznetsov; Donata Rimoldi; Pierre G Coulie; Jean-Charles Cerottini; Victor Jongeneel
HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
The Journal of biological chemistry 1996;271(21):12463-71.
1995: Francis Brasseur; Donata Rimoldi; D Liénard; Bernard Lethé; S Carrel; F Arienti; L Suter; R Vanwijck; A Bourlond; Yves Humblet
Expression of MAGE genes in primary and metastatic cutaneous melanoma.
International journal of cancer. Journal international du cancer 1995;63(3):375-80.
1995: S Carrel; F Hartmann; S Salvi; H Albrecht; M Schreyer; Donata Rimoldi
Expression of type A and B tumor necrosis factor (TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma.
International journal of cancer. Journal international du cancer 1995;62(1):76-83.
1994: S Carrel; S Salvi; F Hartmann; Donata Rimoldi
Recognition of HLA-A1 by murine monoclonal antibodies.
Tissue antigens 1994;43(2):110-5.
1993: S Carrel; L Zografos; M Schreyer; Donata Rimoldi
Expression of CALLA/CD10 on human melanoma cells.
Melanoma research 1993;3(5):319-23.
1993: Stephane Plaisance; Eric Rubinstein; A Alileche; D S Han; Y Sahraoui; M C Mingari; R Bellomo; Donata Rimoldi; M P Colombo; Claude Jasmin
Human melanoma cells express a functional interleukin-2 receptor.
International journal of cancer. Journal international du cancer 1993;55(1):164-70.
1993: Donata Rimoldi; S Salvi; F Hartmann; M Schreyer; S Blum; L Zografos; Stephane Plaisance; Bruno Azzarone; S Carrel
Expression of IL-2 receptors in human melanoma cells.
Anticancer research 1993;13(3):555-64.
1993: S Carrel; Donata Rimoldi
Melanoma-associated antigens.
European journal of cancer (Oxford, England : 1990) 1993;29A(13):1903-7.
1991: D Hayoz; Donata Rimoldi; L Kühn; J P Mach; S Carrel
Cloning of an interferon-gamma regulated human melanoma-associated antigen: identity to the intercellular adhesion molecule ICAM-1.
Melanoma research 1991;1(4):251-9.